Abbott Divestment Wins EU OK For $6.6B Solvay Deal
The European Commission signed off Thursday on Abbott Laboratories' $6.6 billion bid for Solvay Group's pharmaceutical business Thursday, with the condition that Abbott sell off Solvay's cystic fibrosis testing business....To view the full article, register now.
Already a subscriber? Click here to view full article